Previous Close | 68.53 |
Open | 68.25 |
Bid | 68.36 x 800 |
Ask | 68.39 x 800 |
Day's Range | 68.16 - 68.79 |
52 Week Range | 60.47 - 76.56 |
Volume | |
Avg. Volume | 6,269,330 |
Market Cap | 211.946B |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | 35.79 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.45 (2.12%) |
Ex-Dividend Date | Feb 22, 2024 |
1y Target Est | N/A |
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.
The FDA approves AstraZeneca's (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11 years.
J&J (JNJ) is set to buy Shockwave Medical (SWAV). FDA approves AstraZeneca's (AZN) Enhertu for metastatic HER2-positive solid tumors.